|Journal||Annals of Oncology|
|Publication status||Published - Apr 2019|
Senan, S., Shire, N., Mak, G., Yao, W., & Jiang, H. (2019). ADRIATIC: A phase III trial of durvalumab 6 tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer. Annals of Oncology, 30, 25-25.